36.43
Precedente Chiudi:
$36.87
Aprire:
$37.34
Volume 24 ore:
562.19K
Relative Volume:
0.36
Capitalizzazione di mercato:
$8.27B
Reddito:
$5.36B
Utile/perdita netta:
$-111.00M
Rapporto P/E:
-84.78
EPS:
-0.4297
Flusso di cassa netto:
$196.00M
1 W Prestazione:
-7.77%
1M Prestazione:
-3.70%
6M Prestazione:
-12.83%
1 anno Prestazione:
-35.84%
Lineage Inc Stock (LINE) Company Profile
Nome
Lineage Inc
Settore
Industria
Telefono
(800) 678-7271
Indirizzo
46500 HUMBOLDT DRIVE, NOVI
Compare LINE vs PLD, PSA, EXR, EGP, CUBE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
LINE
Lineage Inc
|
36.43 | 8.27B | 5.36B | -111.00M | 196.00M | -0.4297 |
|
PLD
Prologis Inc
|
131.75 | 122.47B | 8.79B | 3.57B | 4.12B | 3.5567 |
|
PSA
Public Storage
|
297.72 | 52.25B | 4.82B | 1.80B | 2.90B | 9.0144 |
|
EXR
Extra Space Storage Inc
|
141.37 | 29.85B | 3.38B | 1.02B | 1.69B | 4.5319 |
|
EGP
Eastgroup Properties Inc
|
187.61 | 10.01B | 721.34M | 257.46M | 404.90M | 4.8717 |
|
CUBE
Cubesmart
|
38.65 | 8.78B | 1.08B | 385.85M | 627.25M | 1.68 |
Lineage Inc Stock (LINE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-13 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-12-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-07-01 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-06-23 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-12 | Downgrade | BNP Paribas Exane | Neutral → Underperform |
| 2025-05-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-04-10 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-28 | Iniziato | Citigroup | Neutral |
| 2025-01-14 | Iniziato | Exane BNP Paribas | Neutral |
| 2024-12-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-09-18 | Iniziato | CapitalOne | Overweight |
| 2024-09-16 | Iniziato | CapitalOne | Overweight |
| 2024-08-19 | Iniziato | Deutsche Bank | Hold |
| 2024-08-19 | Iniziato | Evercore ISI | In-line |
| 2024-08-19 | Iniziato | Goldman | Buy |
| 2024-08-19 | Iniziato | JP Morgan | Overweight |
| 2024-08-19 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-08-19 | Iniziato | Mizuho | Neutral |
| 2024-08-19 | Iniziato | Morgan Stanley | Overweight |
| 2024-08-19 | Iniziato | Piper Sandler | Overweight |
| 2024-08-19 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-19 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-19 | Iniziato | Truist | Buy |
| 2024-08-19 | Iniziato | UBS | Neutral |
| 2024-08-19 | Iniziato | Wells Fargo | Equal Weight |
Mostra tutto
Lineage Inc Borsa (LINE) Ultime notizie
Short Interest in Lineage, Inc. (NASDAQ:LINE) Drops By 27.6% - MarketBeat
Ghisallo Capital Management LLC Has $7.73 Million Holdings in Lineage, Inc. $LINE - MarketBeat
GRS Advisors LLC Raises Stock Holdings in Lineage, Inc. $LINE - MarketBeat
Lineage, Inc. Declares Cash Dividend for the First Quarter of 2026, Payable on April 21, 2026 - marketscreener.com
Lineage raises quarterly dividend by 1% to $0.5325/share - MSN
Lineage, Inc. Declares Increased Dividend for First-Quarter 2026 - bdtonline.com
Insider Buying: Brian Culley Acquires 15,000 Shares of Lineage C - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Lineage, Inc. (LINE) Investors to Inquire about Securities Investigation - ACCESS Newswire
Lineage, Inc. $LINE Shares Sold by Quantbot Technologies LP - MarketBeat
Top Lineage Insider Makes Bold New Move With Fresh Share Purchase - TipRanks
Capital Research Global Investors Buys 120,616 Shares of Lineage, Inc. $LINE - MarketBeat
Lineage Inc (LINE) Stock Price Down 4.46% on Mar 12 - GuruFocus
Lineage posts mixed fourth-quarter results as softer 2026 outlook weighs on shares - MSN
Kevin Patrick Marchetti Buys 11,222 Shares of Lineage (NASDAQ:LINE) Stock - MarketBeat
Lineage (NASDAQ:LINE) Price Target Raised to $42.00 at Scotiabank - MarketBeat
Lineage (LINE) Sees Price Target Raised By Scotiabank | LINE Sto - GuruFocus
Lineage Cell Therapeutics, Inc. Files Form 8-K for At-The-Market Offering – Key Company and Security Information (LCTX, NYSEAMER) 232425 - Minichart
Lineage Cell Therapeutics files prospectus supplement for up to $60 million share offering - Investing.com
Lineage Therap Expands ATM Equity Offering Capacity - TipRanks
West Liberty, Lineage team up on sandwich distribution facility - MEAT+POULTRY
Lineage Cell Therapeutics (LCTX) files $100M shelf to issue shares, debt, warrants - Stock Titan
Ligand Pharmaceuticals (LCTX) raises ATM ceiling to $60M with B. Riley - Stock Titan
Scotiabank raises Lineage stock price target on cold storage outlook By Investing.com - Investing.com South Africa
Scotiabank raises Lineage stock price target on cold storage outlook - Investing.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lineage, Inc. (LINE) And Encourages Investors to Reach Out - ACCESS Newswire
Lineage, Inc. $LINE Shares Acquired by Barclays PLC - MarketBeat
Lineage CFO Rob Crisci to retire - MSN
Lineage (LINE) Price Target Increased to $44 by RBC Capital on Q4 FFO Strength - Finviz
US Market Wrap: Is Klotho Neurosciences Inc gaining market shareGap Down & Daily Technical Forecast Reports - baoquankhu1.vn
Lineage Inc (LINE) Stock Price Down 3.87% on Mar 9 - GuruFocus
H.C. Wainwright Maintains Buy on Lineage Cell Therapeutics (LCTX) Mar 2026 - Meyka
2026-03-08 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lineage, Inc. (LINE) And Encourages Stockholders to Reach Out | NDAQ:LINE | Press Release - Stockhouse
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2025 Earnings Call Transcript - Insider Monkey
RBC Capital Reduces PT on Lineage (LINE) Stock - MSN
Why Lineage Cell Therapeutics Inc. stock could outperform in 2026Portfolio Performance Summary & Free Verified High Yield Trade Plans - Naître et grandir
Lineage, Inc. Earnings Call Balances Progress And Pressure - The Globe and Mail
Can Lineage Cell Therapeutics Inc. stock resist market sell offsQuarterly Growth Report & Long Hold Capital Preservation Plans - Naître et grandir
Lineage Cell (LCTX) grants CFO 1.05M employee stock options - Stock Titan
Lineage Cell Therapeutics (LCTX) grants 900,000 stock options to General Counsel - Stock Titan
Lineage Inc (LINE) Trading Down 3.24% on Mar 6 - GuruFocus
Lineage Cell Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides B - PharmiWeb.com
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Business Wire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Stockholders to Connect - ACCESS Newswire
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 - Investing News Network
LINE PE Ratio & Valuation, Is LINE Overvalued - Intellectia AI
LCTX SEC FilingsLineage Cell The 10-K, 10-Q, 8-K Forms - Stock Titan
A Look Ahead: Lineage Cell Therapeutics's Earnings Forecast - Benzinga
Lineage (LINE) Is Up 5.1% After Returning to Quarterly Profitability on Flat SalesWhat's Changed - simplywall.st
Analysts Offer Insights on Real Estate Companies: Equity Residential (EQR) and Lineage, Inc. (LINE) - The Globe and Mail
LINE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Lineage Inc Azioni (LINE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):